Abstract | Purpose: Methods: To study the consequence of vitamin A dimerization to RPE atrophic changes, we used a rodent model with accelerated vitamin A dimerization, Abca4-/-/Rdh8-/- mice, and the vitamin A analog C20D3-vitamin A to selectively ameliorate the accelerated rate of vitamin A dimerization. Results: We show that ameliorating the rate of vitamin A dimerization with C20D3-vitamin A mitigates pathological changes observed in the prodromal phase of the most prevalent retinal degenerative diseases, including fundus autofluorescence changes, dark adaptation delays, and signature RPE atrophic changes. Conclusions: Data demonstrate that the dimerization of vitamin A during the vitamin A cycle is sufficient alone to cause the prerequisite RPE atrophic changes thought to be responsible for the leading causes of irreversible blindness and that correcting the dimerization rate with C20D3-vitamin A may be sufficient to prevent the RPE atrophic changes. Translational Relevance:
|
Authors | Dan Zhang, Kiera Robinson, Ilyas Washington |
Journal | Translational vision science & technology
(Transl Vis Sci Technol)
Vol. 10
Issue 14
Pg. 8
(12 01 2021)
ISSN: 2164-2591 [Electronic] United States |
PMID | 34878528
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ATP-Binding Cassette Transporters
- Abca4 protein, mouse
- Vitamin A
|
Topics |
- ATP-Binding Cassette Transporters
- Animals
- Macular Degeneration
(genetics, prevention & control)
- Mice
- Retinal Degeneration
- Retinal Pigment Epithelium
(metabolism)
- Stargardt Disease
- Vitamin A
(metabolism)
|